Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEGAPORT LIMITED Capital/Financing Update 2018

Nov 28, 2018

65363_rns_2018-11-28_2d53e70a-4e6e-4cd2-bf46-39c719bd7114.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

Megaport Limited ( Megaport )

ABN

46 607 301 959

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1
+Class of+securities issued or to
be issued
2
Number of+securities issued or
to be issued (if known) or
maximum number which may
be issued
Fully paid ordinary shares
300,000 fully paid ordinary shares (Series A New
Shares);
1,667 fully paid ordinary shares (Series B New
Shares); and
258 fully paid ordinary shares (Series C New
Shares),
(together, theNew Shares)
175,000 options (Series A Options);
2,000,000 options (Series B Options),
(together,theOptions)
3
Principal
terms
of
the
+securities
(e.g.
if
options,
exercise price and expiry date; if
partly
paid
+securities,
the
amount outstanding and due
dates
for
payment;
if
+convertible
securities,
the
conversion price and dates for
conversion)
The New Shares will be issued on the same terms as
existing fully paid ordinary shares in Megaport.
The Series A Options will be granted over 175,000
unissued fully paid ordinary shares in Megaport at
an exercise price of $2.72. The Series A Options will
vest (and may therefore be exercised) as follows:
(a) 50,000 Series A Options on 1 October 2019;
(b) 25,000 Series A Options on 31 October 2019;
(c) 50,000 Series A Options on 1 October 2020;
(d) 25,000 Series A Options on 31 October 2020; and
(e) 25,000 Series A Options on 31 October 2021,
(each, aVesting Date).
The Series A Options will expire on the first
anniversary of the relevant Vesting Date.
The Series B Options will be granted over 2,000,000
unissued fully paid ordinary shares in Megaport at
an exercise price of $3.60. The Series B Options will
vest (and may therefore be exercised) as follows:
(a) 1,000,000 Series B Options on 1 July 2019; and
(b) subject to the vesting conditions below,
1,000,000 Series B Options (Second Tranche
Series B Options) on 29 November 2020,
(each, aVesting Date).
The Second Tranche Series B Options will vest if:
(1) the share price for Megaport reaches $5.00 or
more per fully paid ordinary share in Megaport for
a consecutive period of 30 days; or
(2) Megaport is subject to a change of control
on or before 29 November 2018.
The Series B Options will expire on the first
anniversaryof the relevant VestingDate.
  • See chapter 19 for defined terms.

Appendix 3B Page 2

04/03/2013

4
Do the+securities rank equally
in all respects from the+issue
date with an existing+class of
quoted+securities?
If the additional+securities do
not rank equally, please state:
• the date from which they do
• the extent to which they
participate
for
the
next
dividend, (in the case of a
trust,
distribution)
or
interest payment
• the extent to which they do
not rank equally, other than
in
relation
to
the
next
dividend,
distribution
or
interest payment
5
Issue price or consideration
6
Purpose of the issue
(If issued as consideration for
the acquisition of assets, clearly
identify those assets)
6a
Is the entity an+eligible entity
that
has
obtained
security
holder approval under rule 7.1A?
If Yes, complete sections 6b – 6h
in relation to the+securities the
subject of this Appendix 3B, and
comply with section 6i
6b
The date the security holder
resolution under rule 7.1A
was passed
6c
Number of+securities issued
without
security
holder
approval under rule 7.1
The New Shares will rank equally in all respects
with existing fully paid ordinary shares in
Megaport.
The fully paid ordinary shares issued upon exercise
of the Options will rank equally in all respects with
existing fully paid ordinary shares in Megaport.
$1.25 per Series A New Share
$2.02 per Series B New Share
Nil per Series C New Share
Nilper Option
The Series A New Shares and Series B New Shares
are issued following the exercise of options granted
under Megaport’s Employee Share Option Plan
(ESOP General).
The Series C New Shares are issued under
Megaport’s Employee Share Plan (A$1,000 Award)
(Award Plan).
The Options aregranted under the ESOP General.
No
Not applicable
Not applicable
6d
Number of+securities issued
with security holder approval
under rule 7.1A
6e
Number of+securities issued
with security holder approval
under rule 7.3, or another
specific security holder approval
(specify date of meeting)
6f
Number of+securities issued
under an exception in rule 7.2
6g
If+securities issued under rule
7.1A, was issue price at least 75%
of 15 day VWAP as calculated
under rule 7.1A.3? Include the
+issue date and both values.
Include the source of the VWAP
calculation.
6h
If+securities were issued under
rule
7.1A
for
non-cash
consideration, state date on
which
valuation
of
consideration was released to
ASX Market Announcements
6i
Calculate the entity’s remaining
issue capacity under rule 7.1 and
rule 7.1A – complete Annexure 1
and release to ASX Market
Announcements
7
+Issue dates
Note: The issue date may be prescribed by
ASX (refer to the definition of issue date in
rule 19.12). For example, the issue date for a
pro rata entitlement issue must comply with
the applicable timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
8
Number
and
+class
of
all
+securities
quoted
on
ASX
(_including_the
+securities in
section 2 if applicable)
Not applicable Not applicable
Not applicable
301,925 fully paid ordinary shares
2,175,000 options over unissued fully paid ordinary
shares

Not applicable
Not applicable
Capacity remaining under ASX Listing Rule 7.1 –
17,791,123
Capacity remaining under ASX Listing Rule 7.1A –
Not applicable
29 November 2018
Number +Class
118,607,488 Fully
paid
ordinary
shares
(2,500,000 of which are subject
to voluntary escrow)
  • See chapter 19 for defined terms.

Appendix 3B Page 4

04/03/2013

9
Number
and
+class
of
all
+securities not quoted on ASX
(_including_the
+securities in
section 2 if applicable)
Number +Class
2,175,000 Options granted under the ESOP
General on 29 November 2018, of
which 175,000 have an exercise
price of $2.72 and 2,000,000 of
which have an exercise price of
$3.60 (being the subject of this
Appendix 3B)
100,000 Options granted under the ESOP
General on 9 November 2018 with
an exercise price of $2.66
100,000 Options granted under the ESOP
General on 16 October 2018 with
an exercise price of $2.74
2,710,000 Options granted under the ESOP
General on 3 September 2018
with an exercise price of $3.26
610,000 Options granted under the ESOP
General on 2 July 2018 with an
exercise price of $3.22
1,200,000 Options granted under the ESOP
General on 3 April 2018 with an
exercise price of $2.93
220,000 Options granted under the ESOP
General on 31 March 2018 with an
exercise price of $3.07
50,000 Options granted under the ESOP
General on 25 July 2017 with an
exercise price of $1.75
10,000 Options granted under the ESOP
General on 14 July 2017 with an
exercise price of $1.79
49,330 Options granted under the ESOP
General on 1 January 2017 with an
exercise price of $1.84
100,000 Options granted under the ESOP
General on 5 December 2016 with
an exercise price of $2.02
10
Dividend policy (in the case of a
trust, distribution policy) on the
increased capital (interests)
199,999 Options granted under the ESOP
General on 17 October 2016 with
an exercise price of $2.02
200,000 Options granted under the ESOP
General on 5 October 2016 with
an exercise price of $2.02
93,334 Options granted under the ESOP
General on 30 September 2016
with an exercise price of $2.02
80,000 Options granted under the ESOP
General on 12 September 2016
with an exercise price of $1.91
33,334 Options granted under the ESOP
General on 5 September 2016
with an exercise price of $1.84
133,334 Options granted under the ESOP
General on 23 August 2016 with
an exercise price of $1.85
800,000 Restricted options granted to
senior employees and Non-
Executive Directors under the
2015 Employee Share Option Plan
(as disclosed in Megaport’s
Prospectus dated 20 November
2015)
The New Shares will rank for dividends declared on
or after the date of issue but will carry no right to
receive any dividend before the date of issue.
The fully paid ordinary shares issued on exercise of
the Options will rank for dividends declared on are
after the date of issue but will carry no right to
receive anydividend before the date of issue.

Part 2 - Pro rata issue

11 Is security holder approval Not applicable required?

  • See chapter 19 for defined terms.

Appendix 3B Page 6

04/03/2013

12
Is the issue renounceable or non-
renounceable?
13
Ratio in which the+securities
will be offered
14
+Class of+securities to which the
offer relates
15
+Record
date
to
determine
entitlements
16
Will
holdings
on
different
registers (or subregisters) be
aggregated
for
calculating
entitlements?
17
Policy for deciding entitlements
in relation to fractions
18
Names of countries in which the
entity has security holders who
will not be sent new offer
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19
Closing
date
for
receipt
of
acceptances or renunciations
20
Names of any underwriters
21
Amount of any underwriting fee
or commission
22
Names of any brokers to the
issue
23
Fee or commission payable to
the broker to the issue
24
Amount of any handling fee
payable to brokers who lodge
acceptances or renunciations on
behalf of security holders
25
If the issue is contingent on
security holders’ approval, the
date of the meeting
26
Date entitlement and acceptance
form and offer documents will be
sent to persons entitled
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
27
If the entity has issued options,
and the terms entitle option
holders
to
participate
on
exercise, the date on which
notices will be sent to option
holders
28
Date rights trading will begin (if
applicable)
29
Date rights trading will end (if
applicable)
30
How do security holders sell
their entitlements_in full_through
a broker?
31
How do security holders sell_part_
of their entitlements through a
broker
and
accept
for
the
balance?
32
How do security holders dispose
of their entitlements (except by
sale through a broker)?
33
+Issue date
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

  • 34 Type of[+] securities ( tick one )

  • (a) +Securities described in Part 1

  • (b) All other[+] securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders

  • See chapter 19 for defined terms.

Appendix 3B Page 8

04/03/2013

36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

37 A copy of any trust deed for the additional[+] securities

Entities that have ticked box 34(b)

38 Number of[+] securities for which Not applicable +quotation is sought 39 +Class of +securities for which Not applicable quotation is sought 40 Do the[+] securities rank equally in Not applicable all respects from the[+] issue date with an existing[+] class of quoted +securities? If the additional[+] securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 41 Reason for request for quotation Not applicable now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another[+] security, clearly identify that other[+] security) Number +Class 42 Number and +class of all Not applicable Not applicable +securities quoted on ASX ( including the[+] securities in clause 38)

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted +quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: ............................................................ Date: 29 November 2018 Company Secretary

Print name: Celia Pheasant, Company Secretary

  • See chapter 19 for defined terms.

Appendix 3B Page 10

04/03/2013

– Appendix 3B Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

Part 1 Part 1
Rule 7.1– Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from whichthe placement
capacity is calculated
Insertnumber of fully paid+ordinary securities on
issue 12 months before the+issue date or date of
agreement to issue
101,471,243
Addthe following:
•Number of fully paid+ordinary securities issued
in that 12 month period under an exception in
rule 7.2
•Number of fully paid+ordinary securities issued
in that 12 month period with shareholder
approval
•Number of partly paid+ordinary securities that
became fully paid in that 12 month period
Note:
• Include only ordinary securities here– other
classes of equity securities cannot be added
• Include here (if applicable) the securities the
subject of the Appendix 3B to which this form is
annexed
• It may be useful to set out issues of securities on
different dates as separate line items
29 November 2018–301,925 fully
paid ordinary shares (the subject of
this Appendix 3B)
9 November 2018–118,333 fully
paid ordinary shares
30 October 2018–80,001 fully paid
ordinary shares
16 October 2018–36,666 fully paid
ordinary shares
27 September 2018–93,334 fully
paid ordinary shares
29 August 2018–79,001 fully paid
ordinary shares
31 July 2018–95,046 fully paid
ordinary shares
31 May 2018–69,999 fully paid
ordinary shares
20 April 2018–2,666,271 fully paid
ordinary shares
13 April 2018–22,336 fully paid
ordinary shares
26 March 2018–13,333,334 fully
paid ordinary shares
9 March 2018–145,000 fully paid
ordinary shares
18 December 2017–94,999 fully
paid ordinary shares
  • See chapter 19 for defined terms.

Appendix 3B Page 11

04/03/2013

Subtractthe number of fully paid+ordinary
securities cancelled during that 12 month period
Nil
“A” 118,607,488
Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply “A” by 0.15 17,791,123
Step 3: Calculate “C”, the amount of placement capacity under rule 7.1
that has already been used
Insertnumber of+equity securities issued or
agreed to be issued in that 12 month period_not_
counting_those issued:
•Under an exception in rule 7.2
•Under rule 7.1A
•With security holder approval under rule 7.1 or
rule 7.4
_Note:

• This applies to equity securities, unless
specifically excluded– not just ordinary
securities
• Include here (if applicable) the securities the
subject of the Appendix 3B to which this form is
annexed
• It may be useful to set out issues of securities on
different dates as separate line items
Nil
“C” Nil
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement
capacity under rule 7.1
“A” x 0.15
Note: number must be same as shown in Step 2
17,791,123
Subtract “C”
Note: number must be same as shown in Step 3
Nil
Total [“A” x 0.15] – “C” 17,791,123
Note: this is the remaining placement
capacity under rule 7.1
capacity under rule 7.1
“A” x 0.15 17,791,123
Note: number must be same as shown in Step 2
Subtract “C” Nil
Note: number must be same as shown in Step 3
Total [“A” x 0.15] – “C” 17,791,123
Note: this is the remaining placement
capacity under rule 7.1
  • See chapter 19 for defined terms.

Appendix 3B Page 12

04/03/2013

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

Part 2 Part 2
Rule 7.1A– Additional placement capacity for eligible entities
Step 1: Calculate “A”, the base figure from which the placement capacity
is calculated
“A”
Note: number must be same as shown in Step 1 of
Part 1
Not applicable
Step 2: Calculate 10% of “A”
“D” 0.10
Note: this value cannot be changed
Multiply “A” by 0.10 Not applicable
Step 3: Calculate “E”, the amount of placementcapacity under rule 7.1A
that has already been used
Insertnumber of+equity securities issued or
agreed to be issued in that 12-month period under
rule 7.1A
Notes:
• This applies to equity securities– not just
ordinary securities
• Include here– if applicable– the securities the
subject of the Appendix 3B to which this form is
annexed
• Do not include equity securities issued under
rule 7.1 (they must be dealt with in Part 1), or for
which specific security holder approval has been
obtained
• It may be useful to set out issues of securities on
different dates as separate line items
Not applicable
“E” Not applicable
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement
capacity under rule 7.1A
“A” x 0.10
Note: number must be same as shown in Step 2
Not applicable
Subtract “E”
Note: number must be same as shown in Step 3
Not applicable
Total [“A” x 0.10] – “E” Not applicable
Note: this is the remaining placement
capacity under rule 7.1A
  • See chapter 19 for defined terms.

Appendix 3B Page 13

04/03/2013